Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement

…, JA Hirsch, M Wintermark, G Albers, HH Woo… - Stroke, 2013 - Am Heart Assoc
Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …

Benign prostatic hyperplasia

…, DDM Thomas, L Laor, T Hossack, HH Woo… - Nature reviews Disease …, 2016 - nature.com
Benign prostatic hyperplasia (BPH), which causes lower urinary tract symptoms (LUTS), is a
common diagnosis among the ageing male population with increasing prevalence. Many …

Function of root border cells in plant health: Pioneersin the rhizosphere

…, LA Brigham, F Wen, HH Woo… - Annual review of …, 1998 - annualreviews.org
▪ Abstract Plants dedicate a large amount of energy to the regulated production of living cells
programmed to separate from roots into the external environment. This unusual process …

Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial

…, I Szikora, G Lanzino, CJ Moran, HH Woo… - Radiology, 2013 - pubs.rsna.org
Purpose To evaluate the safety and effectiveness of the Pipeline Embolization Device (PED;
ev3/Covidien, Irvine, Calif) in the treatment of complex intracranial aneurysms. Materials …

[HTML][HTML] Improved outcomes with enzalutamide in biochemically recurrent prostate cancer

…, B Venugopal, A Villers, HH Woo… - … England Journal of …, 2023 - Mass Medical Soc
Background Patients with prostate cancer who have high-risk biochemical recurrence have
an increased risk of progression. The efficacy and safety of enzalutamide plus androgen-…

The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance …

…, B Namdarian, J Kapoor, O Alghazo, HH Woo… - European urology, 2021 - Elsevier
Background Multiparametric magnetic resonance imaging (MRI) is validated for the
detection of clinically significant prostate cancer (csPCa), although patients with negative/equivocal …

Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the …

…, CG McDougall, I Szikora, G Lanzino, HH Woo… - …, 2017 - journals.lww.com
… Dr Woo's institution received funds for grants or for pending grants from Siemens and from
MicroVention; he received royalties paid by Codman & Shurtleff for an acute stroke device …

Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device

D Fiorella, HH Woo, FC Albuquerque, PK Nelson - Neurosurgery, 2008 - journals.lww.com
OBJECTIVE: The Pipeline embolization device (PED; Chestnut Medical, Menlo Park, CA) is
a new endovascular construct designed to exclude aneurysms from the parent …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

…, CI Tang, S Turner, KL Wiltshire, HH Woo… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

[HTML][HTML] Current status of biomarkers for prostate cancer

VM Velonas, HH Woo, CG dos Remedios… - International journal of …, 2013 - mdpi.com
Prostate cancer (PCa) is a leading cause of cancer-related death of men globally. Since its
introduction, there has been intense debate as to the effectiveness of the prostate specific …